Drupal.behaviors.print = function(context) {window.print();window.close();}>
Arrowhead Inks Non-RNAi Tech-Evaluation Deal with Merck Subsidiary
August 16, 2012
Arrowhead Inks Non-RNAi Tech-Evaluation Deal with Merck Subsidiary
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Arrowhead Inks Peptide Delivery Tech Deal with Shire
December 20, 2012 / Gene Silencing News
Arrowhead Chief Sees Little Cost Increase Associated with Newly Acquired Peptide Tech
April 19, 2012 / Gene Silencing News
Arrowhead Picks Up Drug-Delivery Technology through Alvos Acquisition
April 12, 2012 / Gene Silencing News
Calando, Others Miss 2010 Partnering Guidance as Industry Takes Sober View of RNAi
January 6, 2011 / Gene Silencing News
Arrowhead Subsidiary Sees Phase I Data Publication as Key to Industry Partnership
February 18, 2010 / Gene Silencing News